Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - CAPITAL EXPENDITURES
Capital Expenditures IBRX - ImmunityBio, Inc.
-30.6 M
LAST VALUE
4.54%
2 YEAR CAGR
-18.48%
5 YEAR CAGR
-151.67%
10 YEAR CAGR